Tag: APAS Independence
AstraZeneca backs LBT Innovations’ drug manufacturing AI development
LBT Innovations has partnered with AstraZeneca to develop artificial intelligence software that would be used in drug manufacturing.
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
